Q3 2019 Earnings Estimate for Elanco Animal Health Issued By William Blair (NASDAQ:ELAN)

Elanco Animal Health (NASDAQ:ELAN) – Stock analysts at William Blair reduced their Q3 2019 earnings per share (EPS) estimates for shares of Elanco Animal Health in a report issued on Wednesday, August 14th. William Blair analyst J. Kreger now forecasts that the company will earn $0.26 per share for the quarter, down from their prior forecast of $0.27. William Blair also issued estimates for Elanco Animal Health’s Q1 2020 earnings at $0.26 EPS.

Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.02. The business had revenue of $781.60 million for the quarter, compared to analyst estimates of $781.49 million. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year.

Other research analysts have also recently issued reports about the stock. UBS Group raised shares of Elanco Animal Health from a “sell” rating to a “neutral” rating and reduced their target price for the stock from $31.00 to $30.00 in a research report on Thursday. BMO Capital Markets boosted their target price on shares of Elanco Animal Health from $32.00 to $35.00 and gave the stock a “market perform” rating in a research report on Friday, May 10th. Guggenheim initiated coverage on shares of Elanco Animal Health in a research report on Wednesday, May 22nd. They set a “neutral” rating on the stock. Finally, Zacks Investment Research cut shares of Elanco Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, July 10th. Nine analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Elanco Animal Health presently has an average rating of “Hold” and a consensus target price of $33.72.

NASDAQ ELAN opened at $29.36 on Thursday. The company’s fifty day simple moving average is $32.76 and its 200-day simple moving average is $31.92. Elanco Animal Health has a 52 week low of $28.00 and a 52 week high of $37.61.

Several hedge funds and other institutional investors have recently bought and sold shares of ELAN. Eaton Vance Management increased its stake in Elanco Animal Health by 3.9% during the second quarter. Eaton Vance Management now owns 349,388 shares of the company’s stock valued at $11,809,000 after purchasing an additional 12,975 shares during the last quarter. Amundi Pioneer Asset Management Inc. increased its stake in Elanco Animal Health by 4.4% during the second quarter. Amundi Pioneer Asset Management Inc. now owns 11,356,674 shares of the company’s stock valued at $383,857,000 after purchasing an additional 478,550 shares during the last quarter. Equitable Trust Co. increased its stake in Elanco Animal Health by 50.2% during the second quarter. Equitable Trust Co. now owns 114,485 shares of the company’s stock valued at $3,869,000 after purchasing an additional 38,254 shares during the last quarter. California Public Employees Retirement System increased its stake in Elanco Animal Health by 3.6% during the second quarter. California Public Employees Retirement System now owns 1,253,837 shares of the company’s stock valued at $42,380,000 after purchasing an additional 43,619 shares during the last quarter. Finally, Pictet Asset Management Ltd. increased its stake in Elanco Animal Health by 77.4% during the second quarter. Pictet Asset Management Ltd. now owns 977,509 shares of the company’s stock valued at $33,040,000 after purchasing an additional 426,430 shares during the last quarter.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Recommended Story: What are trading strategies for the 52-week high/low?

Earnings History and Estimates for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.